Cabozantinib significantly improves progression free survival compared to sunitinib as first-line treatment for advanced kidney cancer
Review by a blinded independent radiology review committee (IRC) has [...]
Novel treatment options for kidney cancer presented at ASCO 2017
The following video is an interview between PracticeUpdate and Dr Bradley [...]
16-gene recurrence score for high-risk kidney cancer offers prognostic value
Results from a phase III trial presented at the American [...]
Atezolizumab plus bevacizumab demonstrate encouraging results as first- or second-line treatment for advanced kidney cancer
The results of the IMmotion150 trial, a phase II trial looking [...]
Immunotherapy combined with VEGF inhibitors for kidney cancer
In this video interview, Dr Shilpa Gupta, assistant professor, Haematology, [...]
Neoadjuvant and adjuvant therapy for kidney cancer
A comprehensive review of neoadjuvant therapy and adjuvant therapy for [...]
Alternative sunitinib dosing schedule for the treatment of kidney cancer improves adverse events
Recently, the results of several studies have demonstrated that a [...]
Advances in kidney cancer drug treatments shake up drug choices
The following article provides a comprehensive summary of the changing [...]
Sutent treatment breaks may benefit people with advanced kidney cancer
A recent phase 2 study from American researchers based at [...]
European guidelines for the treatment of kidney cancer have been updated
The European Association of Urology (EAU) Renal Cell Carcinoma (RCC) [...]
